Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
Nov 20, 2009 04:44 PM |
DB
,
PJC
,
VRTX
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Lazard Capital Markets Annual Healthcare Conference
Nov 12, 2009 04:15 PM |
GSK
,
VRTX
Vertex Pharmaceuticals Announces Agreements to Exchange $109.0 Million of its 2013 Convertible Senior Subordinated Notes into Common Stock
Nov 10, 2009 05:47 PM |
VRTX
Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration
Nov 09, 2009 05:27 AM |
VRTX
RidgewaterEquity.com Free Fundamental Sector & Market Research on FLEX, ISIL, VRTX, JNPR, COCO and EBAY
Nov 05, 2009 05:29 AM |
EBAY
,
FLEX
,
ISIL
,
JNPR
,
VRTX
Gloomy Put Options Posturing On Financials ETF
Nov 02, 2009 04:53 PM |
BEBE
,
CF
,
ETFC
,
F
,
HGSI
,
LDK
Innovative Drug Companies Headline The Gainers
Nov 02, 2009 04:49 PM |
AMLN
,
HGSI
,
VRTX
Dr. Stockpick Announces Daily Stock Watch - AMLN, VRTX, HGSI
Nov 02, 2009 09:40 AM |
AMLN
,
HGSI
,
VRTX
More than 80% of Hepatitis C Patients Treated in Study C208 Achieved an SVR with Telaprevir-Based Regimens
Oct 31, 2009 05:30 PM |
VRTX
Vertex Pharmaceuticals Announces Webcast of its Presentations at Two Investor Conferences
Oct 30, 2009 04:57 PM |
VRTX
More..
Earnings roundup: Heartland Financial, Masco
Oct 26, 2009 06:52 PM |
MAS
,
VRTX
,
WCBO
Movers: Home Depot, Wellcare, Lehman Brothers, Target
Aug 20, 2008 10:51 AM |
CME
,
FII
,
GD
,
HD
,
LEH
,
MDT
More..
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Canaccord Adams Global Growth Conference
Aug 06, 2009 04:42 PM |
VRTX
BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Aug 06, 2009 06:53 AM |
ARNA
,
AVII
,
AZN
,
BMR
,
CEPH
,
EPCT
Vertex Pharmaceuticals Reports Second Quarter 2009 Financial Results and Highlights Recent Clinical Progress and Business Development Activity
Aug 05, 2009 04:13 PM |
VRTX
Vertex Pharmaceuticals and Mitsubishi Tanabe Pharma Corporation Amend Agreement to Develop and Commercialize Telaprevir in Asia
Jul 30, 2009 03:38 AM |
VRTX
Vertex Pharmaceuticals Announces the Date of its Second Quarter 2009 Financial Results Conference Call and Webcast
Jul 27, 2009 04:17 PM |
VRTX
Third Rock Ventures Expands Team With Biotech Veterans
Jul 21, 2009 10:02 AM |
CBST
,
ILI
,
VRTX
BenchmarkJournal.Com Free Analyst Review for SWHC, AMAT, SYNA, VRTX, CPHD and AKAM
Jul 13, 2009 10:19 AM |
AKAM
,
AMAT
,
CPHD
,
SWHC
,
SYNA
,
VRTX
Vertex Pharmaceuticals Announces Intention to Sell Its Rights to European Milestone Payments for Telaprevir
Jul 10, 2009 05:36 AM |
VRTX
Jeffrey Leiden M.D., Ph.D. and Dennis Winger Join Vertex Pharmaceuticals’ Board of Directors
Jul 07, 2009 04:33 PM |
VRTX
Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2009 Piper Jaffray Europe Conference
Jun 23, 2009 09:47 AM |
VRTX
More..
Form 4 VERTEX PHARMACEUTICALS For: Nov 18 Filed by: BOGER JOSHUA S (10K)
Nov 19, 2009 03:50 PM
Form 4 VERTEX PHARMACEUTICALS For: Nov 17 Filed by: Kelly Lisa (10K)
Nov 19, 2009 03:40 PM
Form 4 VERTEX PHARMACEUTICALS For: Nov 11 Filed by: BOGER JOSHUA S (10K)
Nov 13, 2009 02:05 PM
Form 4 BOGER JOSHUA S For: Oct 27 (10K)
Nov 05, 2009 04:04 PM
Form 4 VERTEX PHARMACEUTICALS For: Oct 22 Filed by: SMITH IAN F (10K)
Oct 26, 2009 06:20 PM
Form 4 VERTEX PHARMACEUTICALS For: Oct 22 Filed by: Sachdev Amit (10K)
Oct 26, 2009 06:18 PM
Form 4 VERTEX PHARMACEUTICALS For: Oct 22 Filed by: MUELLER PETER (10K)
Oct 26, 2009 06:16 PM
Form 4 VERTEX PHARMACEUTICALS For: Oct 22 Filed by: Kelly Lisa (10K)
Oct 26, 2009 06:15 PM
Form 4 VERTEX PHARMACEUTICALS For: Oct 22 Filed by: BOGER KENNETH S (10K)
Oct 26, 2009 06:13 PM
Form 4 VERTEX PHARMACEUTICALS For: Oct 21 Filed by: BOGER JOSHUA S (10K)
Oct 22, 2009 03:32 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
VRTX
Compare to S&P
YTD
33.58 %
10.34 %
4 Weeks
16.44 %
15.82 %
12 Weeks
9.20 %
2.48 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
9.78 %
EPS Growth in Last Year:
10.75 %
Sales Growth in Last Quarter:
30.91 %
Sales Growth in Last Quarter:
-21.04 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
